-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Elevance Health, Raises Price Target to $404

Benzinga·01/05/2026 14:18:14
Listen to the news
Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $385 to $404.